Gaurav Shah - 18 Nov 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
18 Nov 2025
Net transactions value
-$18,721
Form type
4
Filing time
20 Nov 2025, 16:05:36 UTC
Previous filing
20 Aug 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shah Gaurav CEO, Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Gaurav Shah 20 Nov 2025 0001725922

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $18,721 -6,276 -0.8% $2.98 778,296 18 Nov 2025 Direct F1
holding RCKT Common Stock 207,897 18 Nov 2025 By Spouse
holding RCKT Common Stock 198,341 18 Nov 2025 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.